Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination.
Costs associated with HPV-related diseases such as cervical dysplasia, cervical cancer, and genital warts have not been evaluated in Sweden. These costs must be estimated in order to determine the potential savings if these diseases were eradicated and to assess the combined cost-effectiveness of HP...
Main Authors: | Ellinor Östensson, Maria Fröberg, Amy Leval, Ann-Cathrin Hellström, Magnus Bäcklund, Niklas Zethraeus, Sonia Andersson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4580320?pdf=render |
Similar Items
-
Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico.
by: Ana Patricia Ortiz, et al.
Published: (2017-01-01) -
Correction: Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico.
by: Ana Patricia Ortiz, et al.
Published: (2018-01-01) -
Human Papillomavirus (HPV) and the quadrivalent HPV Vaccine among Brazilian adolescents and parents: Factors associated with and divergences in knowledge and acceptance.
by: Jéssica Menezes Gomes, et al.
Published: (2020-01-01) -
The Use and Neurological Safety of the Quadrivalent Human Papillomavirus (HPV) Vaccine: The Ontario Grade 8 HPV Vaccine Cohort Study
by: Lim, Wen Ting
Published: (2012) -
Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1
by: Michelle S. Cespedes, et al.
Published: (2018-12-01)